Elisa Rosati from the Institute of Clinical Molecular Biology, Christian-Albrechts University of Kiel, Germany, speaks on characterization of SARS-CoV-2 public CD4 αβ T cell clonotypes through reverse epitope discovery, at the second session of our iR Seminar Series.
ALT iReceptor Plus Seminar Series: Theory and Applications of Immune Repertoires